Relationship between results of in vitro susceptibility tests and outcomes following treatment with pirlimycin hydrochloride in cows with subclinical mastitis associated with gram-positive pathogens

Journal of the American Veterinary Medical Association

Volumn 234, Issue 11, 2009, Pages 1437-1446

  Apparao, Dhananjay ^a   Oliveira, Leane ^a   Ruegg, Pamela L ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALIA; BOS; POSIBACTERIA; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS;

ANTIINFECTIVE AGENT; CLINDAMYCIN; DRUG DERIVATIVE; PIRLIMYCIN;

ANIMAL; ANIMAL DISEASE; ANTIBIOTIC RESISTANCE; ARTICLE; CATTLE; CATTLE DISEASE; CLINICAL TRIAL; DRUG EFFECT; FEMALE; GRAM POSITIVE BACTERIUM; GRAM POSITIVE INFECTION; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; TREATMENT OUTCOME;

ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIOLOGICAL TECHNIQUES; CATTLE; CLINDAMYCIN; DRUG RESISTANCE, BACTERIAL; FEMALE; GRAM-POSITIVE BACTERIA; GRAM-POSITIVE BACTERIAL INFECTIONS; MASTITIS, BOVINE; MICROBIAL SENSITIVITY TESTS; TREATMENT OUTCOME;

EID: 67651222623     PISSN: 00031488     EISSN: None     Source Type: Journal    
DOI: 10.2460/javma.234.11.1437     Document Type: Article

References (37)

1. Sandholm M, Kaartinen L, Pyolara S. Bovine mastitis-why does antibiotic therapy not always work? An overview. J Vet Pharmacol Ther 1990; 13: 248-260.
2. Aarestrup FM. Veterinary drug usage and antimicrobial resistance in bacteria of animal origin. Basic Clin Pharmacol Toxicol 2005; 96: 271-281. (Pubitemid 40432474)
3. Pol M, Ruegg PL. Relationship between antimicrobial drug usage and antimicrobial susceptibility of gram-positive mastitis pathogens. J Dairy Sci 2007; 90: 262-273. (Pubitemid 350042857)
4. Gruet P, Maincent P, Berthelot X, et al. Bovine mastitis and intramammary drug delivery: review and perspectives. Adv Drug Deliv Rev 2001; 50: 245-259. (Pubitemid 32735459)
5. Erskine RJ, Kirk JH, Tyler JW, et al. Advances in the therapy for mastitis. Vet Clin North Am Food Anim Pract 1993; 9: 499-517.
6. Constable PD, Morin DE. Treatment of clinical mastitis. Using antimicrobial susceptibility profiles for treatment decisions. Vet Clin North Am Food Anim Pract 2003; 19: 139-155. (Pubitemid 38621927)
7. Owens WE, Ray CH, Watts JL, et al. Comparison of success of antibiotic therapy during lactation and results of antimicrobial susceptibility tests for bovine mastitis. J Dairy Sci 1997; 80: 313-317.
8. Cattell MB, Dinsmore RP, Belschner AP, et al. Environmental gram-positive mastitis treatment: in vitro sensitivity and bacteriologie cure. J Dairy Sci 2001; 84: 2036-2043.
9. Constable PD, Morin DE. Use of antimicrobial susceptibility testing of bacterial pathogens isolated from the milk of dairy cows with clinical mastitis to predict response to treatment with cephapirin and Oxytetracycline. J Am Vet Med Assoc 2002; 221: 103-108.
10. Hoe FG, Ruegg PL. Relationship between antimicrobial susceptibility of clinical mastitis pathogens and treatment outcome in cows. J Am Vet Med Assoc 2005; 227: 1461-1468.
11. Pharmacia & Upjohn. Mastitis review document. Pirsue aqueous gel (pirlimycin hydrochloride aqueous gel) for treatment of clinical and subclinical mastitis in lactating cattle. Kalamazoo, Mich: Pharmacia & Upjohn, 1993.
12. Yancey RJ Jr, Kinney ML, Ford CW Efficacy of lincosaminide antibiotics in the treatment of experimental staphylococcal mastitis in lactating mice. J Antimicrob Chemother 1985; 15: 219-232.
13. Thornsberry C, Marler JK, Watts JL, et al. Activity of pirlimycin against pathogens from cows with mastitis and recommendations for disk diffusion tests. Antimicrob Agents Chemother 1993; 37: 1122-1126. (Pubitemid 23141330)
14. National Mastitis Council. Laboratory handbook on bovine mastitis. Madison, Wis: National Mastitis Council Inc, 1999.
15. Clinical Laboratory Standards Institute. Performance standards for antimicrobial disk and dilution susceptibility tests for bacteria isolated from animal; approved standard - 3rd ed. CLSI document M31A3. Wayne, Pa: Clinical Laboratory Standards Institute, 2007.
16. Jensen MA, Webster JA, Straus N. Rapid identification of bacteria on the basis of polymerase chain reaction-amplified ribosomal DNA spacer polymorphisms. Appl Environ Microbiol 1993; 59: 945-952. (Pubitemid 23096626)
17. Foreman P, Tilsab-Timisjärvi A, Alatossava T. Identification of staphylococcal and streptococcal causes of bovine mastitis using 16S-23S rRNA spacer regions. Microbiology 1997; 143: 3491-3500. (Pubitemid 27496928)
18. Weisblum B. Erythromycin resistance by ribosome modification. Antimicrob Agents Chemother 1995; 39: 577-585.
19. Owens WE, Ray CH, Washbum PJ. Effect of selected antibiotics on Staphylococcus aureus present in milk from infected mammary glands. Zentralbl Veterinarmed [B] 1993; 40: 508-514.
20. Watts JL, Salmon SA. Activity of selected antimicrobial agents against strains of Staphylococcus aureus isolated from bovine intramammary infections that produce ß-lactamase. J Dairy Sci 1997; 80: 788-791.
21. Dohoo IR, Leslie KE. Evaluation of changes in somatic cell counts as indicators of new intramammary infections. Prev Vet Med 1991; 10: 225-237.
22. Schukken YH, Wilson DJ, Welcome F, et al. Monitoring udder health and milk quality using somatic cell counts. Vet Res 2003; 34: 579-596. (Pubitemid 37407272)
23. Seymour EH, Jones GM, McGilliard ML. Effectiveness of intramammary antibiotic therapy based on somatic cell count. J Dairy Sci 1989; 72: 1057-1062.
24. McDermott MP, Erb HN, Natzke RP, et al. Cost benefit analysis of lactation therapy with somatic cell counts as indications for treatment. J Dairy Sci 1983; 66: 1198-1203.
25. Deluyker HA, Van Oye SN, Boucher JF. Factors affecting cure and somatic cell count after pirlimycin treatment of subclinical mastitis in lactating cows. J Dairy Sci 2005; 88: 604-614.
26. Oliver SP, Gillespie BE, Headrick SJ, et al. Efficacy of extended ceftiofur intramammary therapy for treatment of subclinical mastitis in lactating dairy cows. J Dairy Sci 2004; 87: 2393-2400. (Pubitemid 39103963)
27. Ruegg PL. The quest for the perfect test: phenotypic versus genotypic identification of coagulase-negative staphylococci associated with bovine mastitis. Vet Microbiol 2009; 134: 15-19.
28. Erskine R, Cullor J, Schaellibaum MB, et al. Bovine mastitis pathogens and trends in resistance to antibacterial drugs, in Proceedings. 43rd NMC Annu Meet 2004;400-414.
29. Deubler MJ, Cole EJ. Preliminary studies on Pseudomonas mastitis. Am J Vet Res 1955; 16: 511-514.
30. Ziv G. Drug selection and use in mastitis: systemic vs local therapy. J Am Vet Med Assoc 1980; 176: 1109-1115. (Pubitemid 11133181)
31. Owens WE, Watts JL. Effects of milk on activity of antimicrobics against Staphylococcus aureus isolated from bovine udders. J Dairy Sci 1987; 70: 1946-1951.
32. Owens WE, Nickerson SC. Antibiotic levels in milk and mammary tissues during various treatment regimens for bovine mastitis. Agri-Pract 1989; 10: 10-15.
33. Clinical Laboratory Standards Institute. Development of in vitro susceptibility testing criteria and quality control parametersfor veterinary antimicrobial agents; approved guideline-2nd ed. CLSI document M37-A2. Wayne, Pa: Clinical Laboratory Standards Institute, 2002.
34. Forrest A, Nix DE, Ballow CH, et al. Pharmacodynamics of intravenous ciprofloxacin in seriously ill patients. Antimicrob Agents Chemother 1993; 37: 1073-1081. (Pubitemid 23141323)
35. Dingwell RT, Leslie KE, Duffield TF, et al. Efficacy of intramammary tilmicosin and risk factors for cure of Staphylococcus aureus infection in the dry period. J Dairy Sci 2003; 86: 159-168.
36. Gillespie BE, Moorehead H, Lunn P, et al. Efficacy of extended pirlimycin hydrochloride therapy for treatment of environmental Streptococcus spp and Staphylococcus aureus intramammary infections in lactating dairy cows. Vet Ther 2002; 3: 373-380.
37. Middleton JR, Timms LL, Bader GR, et al. Effect of prepartum intramammary treatment with pirlimycin hydrochloride on prevalence of early first-lactation mastitis in dairy heifers. J Am Vet Med Assoc 2005; 227: 1969-1974.